President and CEO

Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer

Braeburn gets FDA approval for opioid use disorder drug after more than 4-year battle

FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder

Camurus announces that Braeburn resubmits NDA for Brixadi™ in the US

Regional Director, Southwest

Braeburn is dedicated to delivering solutions for people living with opioid use disorder. The Regional Director will provide leadership and strategic direction for a diverse team of Account Managers to achieve business performance objectives while ensuring high work standards that are patient centric and customer focused.

Sign up with Google

Sign in with Google